Dr. Green quoted in Cancer Therapy Advisor

A recent study on immunosuppression was performed by Brigham and Women’s Hospital, Boston, Massachusetts, and the American Joint Committee on Cancer. The findings underscore the importance of careful screening and aggressive treatment in immunosuppressed patients, the authors noted. An article in Cancer Therapy Advisor (part of the Haymarket Medical Network) discusses the study overall.

Within the article, Dr. Michele Green, MD, agreed with this conclusion. “Immunosuppressed patients need to be screened more often for skin cancer and treated more aggressively to ensure a better outcome,” she said. “This subset of patients is very vulnerable to poor outcomes and need[s] to be monitored closely.”

View findings from the study at – https://www.cancertherapyadvisor.com/home/cancer-topics/skin-cancer/squamous-cell-carcinoma-scc-immunosuppression-poor-outcomes-risk/2/